Search

everythinglearnresearchcommunity

for

Search:↓

Different drugs are used to manage breeding, prevent or end pregnancy, and treat reproductive issues in dogs and cats.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Some medications can cause acne, and stopping these drugs is the main treatment.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Androgen use may increase the risk of stroke, but more research is needed.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Hair loss linked to higher heart disease risk in both men and women.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Non-obese women with hair loss have higher heart disease risk.

A benign tumor developed at a girl's BCG vaccination site, not previously linked to the vaccine.